Commerce Bank acquired a new position in Danaher Corporation (NYSE:DHR – Free Report) in the 2nd quarter, HoldingsChannel reports. The fund acquired 62,079 shares of the conglomerate’s stock, valued at approximately $44,699,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in DHR. BlackRock Inc. bought a new position in Danaher during the second quarter worth about $10,492,520,000. Norges Bank purchased a new position in shares of Danaher in the fourth quarter worth about $2,177,106,000. Generation Investment Management LLP bought a new stake in shares of Danaher in the second quarter valued at approximately $1,287,949,000. Flossbach Von Storch SE purchased a new stake in shares of Danaher during the 2nd quarter valued at approximately $747,260,000. Finally, Bank of New York Mellon Corp bought a new position in Danaher in the 2nd quarter worth approximately $712,875,000. 79.05% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
DHR has been the subject of a number of recent research reports. Citigroup started coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. Evercore reaffirmed an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Wells Fargo & Company reduced their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Finally, Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.
Danaher Price Performance
Shares of NYSE:DHR opened at $219.42 on Friday. The company has a 50 day moving average of $195.80 and a 200 day moving average of $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company posted $0.77 EPS. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
